0.2300CAD+2.22%Mkt Cap: 63.44M CADP/E: —Last update: 2026-06-01
Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research, development, and commercialization of light activated photo dynamic compounds and their associated drug formulations to treat…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap63.44M CAD
Enterprise Value62.33M CAD
Revenue (TTM)816.47K CAD
Gross Profit507.13K CAD
Net Income (TTM)-4.12M CAD
Revenue/Share0.0030 CAD
Last Price0.2300 CAD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryCA
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-22.50
PEG—
EV/EBITDA-15.57
EV/Revenue76.35
P/S81.48
P/B56.25
EPS (TTM)-0.02
EPS (Forward)-0.01
52W Range
0.150031% of range0.4100
52W High0.4100 CAD
52W Low0.1500 CAD
Profitability
Gross Margin62.11%
Oper. Margin-306.57%
EBITDA Margin0.00%
Profit Margin-504.71%
ROE-231.79%
ROA-117.92%
Growth
Revenue Growth-45.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.29M CAD
CapEx (TTM)48.94K CAD
FCF Margin-245.02%
FCF Yield-3.15%
Net Debt275.14K CAD
Net Debt/EBITDA-0.07
Balance Sheet
Debt/Equity0.26
Current Ratio1.25
Quick Ratio0.85
Book Value/Sh0.0040 CAD
Cash/Share0.0010 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)0.7000 CAD
Target Range0.7000 CAD – 0.7000 CAD
# Analysts1
Ownership
Shares Out.275.82M
Float256.60M
Insiders8.40%
Institutions0.00%
Short Interest
Short Ratio11.3d
Short % Out.2.06%
Shares Short1.75M
Short (prev mo.)35.74K
Technical
SMA 500.2818 (-18.4%)
SMA 2000.2340 (-1.7%)
Beta0.67
S&P 52W Chg27.70%
Avg Vol (30d)516.58K
Avg Vol (10d)464.27K
Technical Indicators
RSI (14)40.7
MACD-0.0186
MACD Signal-0.0174
MACD Hist.-0.0012
BB Upper0.3066 CAD
BB Middle0.2480 CAD
BB Lower0.1894 CAD
BB Width47.27%
ATR (14)0.0285 CAD
Vol Ratio (20d)0.19x